Zynex Inc. (OTCMKTS:ZYXI) – Seethru Equity upped their FY2018 earnings estimates for Zynex in a research note issued to investors on Wednesday. Seethru Equity analyst A. Tandon now anticipates that the company will earn $0.31 per share for the year, up from their previous forecast of $0.28.
Several other equities analysts have also weighed in on the stock. Zacks Investment Research upgraded shares of Zynex from a “hold” rating to a “buy” rating and set a $3.25 price target for the company in a research report on Thursday, November 23rd. ValuEngine lowered shares of Zynex from a “buy” rating to a “hold” rating in a research report on Thursday, January 25th.
Zynex, Inc operates through the Electrotherapy and Pain Management Products segment. The Company conducts its business through its subsidiaries and the operating subsidiary is Zynex Medical, Inc (ZMI). Its other subsidiaries include Zynex Monitoring Solutions, Inc (ZMS) and Zynex Europe, ApS (ZEU). ZMI designs, manufactures and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation.
Receive News & Ratings for Zynex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zynex and related companies with MarketBeat.com's FREE daily email newsletter.